Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified human growth hormone formulations with an increased serum half-life

Modified human growth hormone formulations with an increased serum half-life

US Patent 8178494 · Granted May 15, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Histidyl-tRNA synthetase-Fc conjugates and therapeutics using the same2025
Emollient topical disinfectants2023
Engineered polypeptides having enhanced duration of action2022
Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof2022
Histidyl-tRNA synthetase-Fc conjugates2021
Histidyl-tRNA synthetase-Fc conjugates2020
Histidyl-tRNA synthetase-Fc conjugates2019
Histidyl-tRNA synthetase-Fc conjugates2018
Engineered polypeptides having enhanced duration of action and reduced immunogen2018
PEGylated aspartyl-tRNA synthetase polypeptides2017
Aspartyl-tRNA synthetases2017
PEGylated tyrosyl-tRNA synthetase polypeptides2017